Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiaxing Hengjie Biopharmaceutical, now primarily known as HS Nutra Co., Ltd., is a leading Chinese manufacturer specializing in the research, development, and production of joint health ingredients. Established in 1997 and headquartered in Jiaxing, Zhejiang, the company is a pioneer in the production of chondroitin sulfate, glucosamine, collagen, and hyaluronic acid. It operates a GMP-certified facility and holds a Drug Manufacturing License for chondroitin sulfate as an Active Pharmaceutical Ingredient (API). The company actively validates its products through clinical research, including studies on its branded undenatured type II collagen (Native CT-II) and eggshell membrane (ELASEM) for the treatment of osteoarthritis. With a global distribution network and subsidiaries in the United States and the Netherlands, the company serves the pharmaceutical and nutraceutical industries worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiaxing Hengjie Biopharmaceutical.